EU Commissioner Varhelyi Warns European Healthcare Model is Under Pressure

EU Healthcare Model

EU Commissioner warns healthcare model under pressure

System faces ageing population, worker shortages

EU pushes drug rule reforms to boost resilience

Stock video by tommyvideo via Pixabay

Mar 17, 2026

EU Commissioner Varhelyi Warns European Healthcare Model is Under Pressure

European Commissioner Oliver Varhelyi has identified health as a primary challenge for Europe. According to Euronews, Varhelyi made these remarks at a health summit in Brussels, citing a rising number of non-communicable diseases, shortages of healthcare workers, and a growing ageing population as factors shaping the region's health landscape.

Varhelyi described the European healthcare model as distinct and unique, stating it should be preserved as a value that makes the bloc more reliable for its societies. He cautioned that the system is under pressure and cannot be taken for granted to remain unchanged.

In response, the European Union has presented multiple reforms aimed at strengthening resilience and crisis response. Varhelyi, who took office in 2024, has presented significant legislation governing European health. Driven by medicine shortages and dependencies in the drug supply chain, the bloc agreed on a revamp of its pharmaceutical rules in December 2025.

The Commissioner noted the pharmaceutical industry is a major economic contributor, representing five percent of value added from all manufacturing and almost 11 percent of EU exports. He stated the reform provides an update designed to transform the regulatory system to support groundbreaking therapies, particularly for patients with unmet medical needs.

Following a similar simplification objective, the recently presented EU Biotech Act aims to ease the process of bringing products from the laboratory to the market. Varhelyi explained this act, together with an update on medical devices regulation, has simplification at its core.

He asserted these initiatives will position the European health industry at the forefront of global innovation and deliver the best health technologies to citizens. Varhelyi concluded that this path is the only way to save the unique European healthcare model, arguing that current rules create unnecessary costs, bottlenecks, uncertainty for companies, and delays for patients. He stated that simplifying, implementing, and updating rules moves the bloc toward a future where innovation thrives and ideas become treatments faster.

This report provides a comprehensive view of the penicillins or streptomycins medicaments industry in Europe, tracking demand, supply, and trade flows across the regional value chain. It explains how demand across key channels and end-use segments shapes consumption patterns, while also mapping the role of input availability, production efficiency, and regulatory standards on supply.

Beyond headline metrics, the study benchmarks prices, margins, and trade routes so you can see where value is created and how it moves between exporters and importers within Europe. The analysis is designed to support strategic planning, market entry, portfolio prioritization, and risk management in the penicillins or streptomycins medicaments landscape in Europe.

Quick navigation

Key findings
Report scope
Product coverage
Country coverage
Methodology
Forecasts to 2035
Price analysis
Market participants
Country profiles
How to use this report
FAQ

Key findings

Regional demand is shaped by both household and industrial usage, with trade flows linking supply hubs to import-reliant countries.
Pricing dynamics reflect unit values, freight costs, exchange rates, and regulatory shifts that affect sourcing decisions.
Supply depends on input availability and production efficiency, creating distinct cost curves across Europe.
Market concentration varies by country, creating different competitive landscapes and entry barriers.
The 2035 outlook highlights where capacity investment and demand growth are most aligned within the region.

Report scope

The report combines market sizing with trade intelligence and price analytics for Europe. It covers both historical performance and the forward outlook to 2035, allowing you to compare cycles, structural shifts, and policy impacts across countries and sub-regions.

Market size and growth in value and volume terms
Consumption structure by end-use segments and countries
Production capacity, output, and cost dynamics
Regional trade flows, exporters, importers, and balances
Price benchmarks, unit values, and margin signals
Competitive context and market entry conditions

Product coverage

Prodcom 21201160 - Medicaments of penicillins, streptomycins or derivatives thereof, in doses or p.r.s.

Country coverage

Country profiles and benchmarks

For the regional report, country profiles provide a consistent view of market size, trade balance, prices, and per-capita indicators across Europe. The profiles highlight the largest consuming and producing markets and allow direct benchmarking across peers.

Methodology

The analysis is built on a multi-source framework that combines official statistics, trade records, company disclosures, and expert validation. Data are standardized, reconciled, and cross-checked to ensure consistency across time series.

International trade data (exports, imports, and mirror statistics)
National production and consumption statistics
Company-level information from financial filings and public releases
Price series and unit value benchmarks
Analyst review, outlier checks, and time-series validation

All data are normalized to a common product definition and mapped to a consistent set of codes. This ensures that comparisons across time are aligned and actionable.

Forecasts to 2035

The forecast horizon extends to 2035 and is based on a structured model that links penicillins or streptomycins medicaments demand and supply to macroeconomic indicators, trade patterns, and sector-specific drivers. The model captures both cyclical and structural factors and reflects known policy and technology shifts within Europe.

Historical baseline: 2012-2025
Forecast horizon: 2026-2035
Scenario-based sensitivity to income growth, substitution, and regulation
Capacity and investment outlook for major producing countries

Each country projection is built from its own historical pattern and the regional context, allowing the report to show where growth is concentrated and where risks are elevated.

Price analysis and trade dynamics

Prices are analyzed in detail, including export and import unit values, regional spreads, and changes in trade costs. The report highlights how seasonality, freight rates, exchange rates, and supply disruptions influence pricing and margins.

Price benchmarks by country and sub-region
Export and import unit value trends
Seasonality and calendar effects in trade flows
Price outlook to 2035 under baseline assumptions

Profiles of market participants

Key producers, exporters, and distributors are profiled with a focus on their operational scale, geographic footprint, product mix, and market positioning. This helps identify competitive pressure points, partnership opportunities, and routes to differentiation.

Business focus and production capabilities
Geographic reach and distribution networks
Cost structure and pricing strategy indicators
Compliance, certification, and sustainability context

How to use this report

Quantify regional demand and identify the most attractive country markets
Evaluate export opportunities and prioritize target destinations
Track price dynamics and protect margins
Benchmark performance against regional competitors
Build evidence-based forecasts for investment decisions

This report is designed for manufacturers, distributors, importers, wholesalers, investors, and advisors who need a clear, data-driven picture of penicillins or streptomycins medicaments dynamics in Europe.

FAQ

What is included in the penicillins or streptomycins medicaments market in Europe?

The market size aggregates consumption and trade data at country and sub-regional levels, presented in both value and volume terms.

How are the forecasts to 2035 built?

The projections combine historical trends with macroeconomic indicators, trade dynamics, and sector-specific drivers.

Does the report cover prices and margins?

Yes, it includes export and import unit values, regional spreads, and a pricing outlook to 2035.

Which countries are profiled in detail?

The report provides profiles for the largest consuming and producing countries in Europe.

Can this report support market entry decisions?

Yes, it highlights demand hotspots, trade routes, pricing trends, and competitive context.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND THE AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and its Prospects
1. MARKET SIZE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
2. CONSUMPTION BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
3. MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION

Finding New Products to Diversify Your Business
- This Chapter is Available Only for the Professional EditionPRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCTS
4. MOST TRADED PRODUCTS
5. MOST PROFITABLE PRODUCTS FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
- This Chapter is Available Only for the Professional EditionPRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Export
- This Chapter is Available Only for the Professional EditionPRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
2. PRODUCTION BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
8. IMPORTS

The Largest Import Supplying Countries
1. IMPORTS: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
2. IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
3. IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
9. EXPORTS

The Largest Destinations for Exports
1. EXPORTS: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
2. EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
3. EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
- This Chapter is Available Only for the Professional EditionPRO
11. COUNTRY PROFILES

The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO
1. 11.1
  Albania
  - Market Size
  - Production
  - Imports
  - Exports
2. 11.2
  Andorra
  - Market Size
  - Production
  - Imports
  - Exports
3. 11.3
  Austria
  - Market Size
  - Production
  - Imports
  - Exports
4. 11.4
  Belarus
  - Market Size
  - Production
  - Imports
  - Exports
5. 11.5
  Belgium
  - Market Size
  - Production
  - Imports
  - Exports
6. 11.6
  Bosnia and Herzegovina
  - Market Size
  - Production
  - Imports
  - Exports
7. 11.7
  Bulgaria
  - Market Size
  - Production
  - Imports
  - Exports
8. 11.8
  Croatia
  - Market Size
  - Production
  - Imports
  - Exports
9. 11.9
  Czech Republic
  - Market Size
  - Production
  - Imports
  - Exports
10. 11.10
  Denmark
  - Market Size
  - Production
  - Imports
  - Exports
11. 11.11
  Estonia
  - Market Size
  - Production
  - Imports
  - Exports
12. 11.12
  Faroe Islands
  - Market Size
  - Production
  - Imports
  - Exports
13. 11.13
  Finland
  - Market Size
  - Production
  - Imports
  - Exports
14. 11.14
  France
  - Market Size
  - Production
  - Imports
  - Exports
15. 11.15
  Germany
  - Market Size
  - Production
  - Imports
  - Exports
16. 11.16
  Gibraltar
  - Market Size
  - Production
  - Imports
  - Exports
17. 11.17
  Greece
  - Market Size
  - Production
  - Imports
  - Exports
18. 11.18
  Holy See
  - Market Size
  - Production
  - Imports
  - Exports
19. 11.19
  Hungary
  - Market Size
  - Production
  - Imports
  - Exports
20. 11.20
  Iceland
  - Market Size
  - Production
  - Imports
  - Exports
21. 11.21
  Ireland
  - Market Size
  - Production
  - Imports
  - Exports
22. 11.22
  Italy
  - Market Size
  - Production
  - Imports
  - Exports
23. 11.23
  Latvia
  - Market Size
  - Production
  - Imports
  - Exports
24. 11.24
  Lithuania
  - Market Size
  - Production
  - Imports
  - Exports
25. 11.25
  Luxembourg
  - Market Size
  - Production
  - Imports
  - Exports
26. 11.26
  North Macedonia
  - Market Size
  - Production
  - Imports
  - Exports
27. 11.27
  Malta
  - Market Size
  - Production
  - Imports
  - Exports
28. 11.28
  Moldova
  - Market Size
  - Production
  - Imports
  - Exports
29. 11.29
  Montenegro
  - Market Size
  - Production
  - Imports
  - Exports
30. 11.30
  Netherlands
  - Market Size
  - Production
  - Imports
  - Exports
31. 11.31
  Norway
  - Market Size
  - Production
  - Imports
  - Exports
32. 11.32
  Poland
  - Market Size
  - Production
  - Imports
  - Exports
33. 11.33
  Portugal
  - Market Size
  - Production
  - Imports
  - Exports
34. 11.34
  Romania
  - Market Size
  - Production
  - Imports
  - Exports
35. 11.35
  Russia
  - Market Size
  - Production
  - Imports
  - Exports
36. 11.36
  San Marino
  - Market Size
  - Production
  - Imports
  - Exports
37. 11.37
  Serbia
  - Market Size
  - Production
  - Imports
  - Exports
38. 11.38
  Slovakia
  - Market Size
  - Production
  - Imports
  - Exports
39. 11.39
  Slovenia
  - Market Size
  - Production
  - Imports
  - Exports
40. 11.40
  Spain
  - Market Size
  - Production
  - Imports
  - Exports
41. 11.41
  Sweden
  - Market Size
  - Production
  - Imports
  - Exports
42. 11.42
  Switzerland
  - Market Size
  - Production
  - Imports
  - Exports
43. 11.43
  Ukraine
  - Market Size
  - Production
  - Imports
  - Exports
44. 11.44
  United Kingdom
  - Market Size
  - Production
  - Imports
  - Exports
45. 11.45
  Liechtenstein
  - Market Size
  - Production
  - Imports
  - Exports
46. 11.46
  Isle of Man
  - Market Size
  - Production
  - Imports
  - Exports
47. 11.47
  Monaco
  - Market Size
  - Production
  - Imports
  - Exports
LIST OF TABLES
1. Key Findings In 2025
2. Market Volume, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
3. Market Value: Historical Data (2012–2025) and Forecast (2026–2035)
4. Per Capita Consumption, by Country, 2022–2025
5. Production, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
6. Imports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
7. Imports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
8. Import Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
9. Exports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
10. Exports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
11. Export Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
LIST OF FIGURES
1. Market Volume, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
2. Market Value: Historical Data (2012–2025) and Forecast (2026–2035)
3. Consumption, by Country, 2025
4. Market Volume Forecast to 2035
5. Market Value Forecast to 2035
6. Market Size and Growth, By Product
7. Average Per Capita Consumption, By Product
8. Exports and Growth, By Product
9. Export Prices and Growth, By Product
10. Production Volume and Growth
11. Exports and Growth
12. Export Prices and Growth
13. Market Size and Growth
14. Per Capita Consumption
15. Imports and Growth
16. Import Prices
17. Production, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
18. Production, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
19. Production, by Country, 2025
20. Production, In Physical Terms, by Country: Historical Data (2012–2025) and Forecast (2026–2035)
21. Imports, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
22. Imports, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
23. Imports, In Physical Terms, By Country, 2025
24. Imports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
25. Imports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
26. Import Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
27. Exports, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
28. Exports, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
29. Exports, In Physical Terms, By Country, 2025
30. Exports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
31. Exports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
32. Export Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)

Recommended posts

RTW Investments Boosts Cogent Biosciences Stake in Q1 2026

DAFNA Capital Reduces Stake in iShares Biotechnology ETF in Q4 2025

BioMarin Q4 2025 Revenue Beats Estimates but 2026 Guidance Concerns Investors

Boone Capital Management Sells Entire Cogent Biosciences Stake in Q4 2025